Monday, December 30, 2019

AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer

AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer The drug is now the only approved medicine in biomarker-selected patients with advanced pancreatic cancer.

from Moneycontrol Business News https://ift.tt/35awRrv

No comments:

Post a Comment

Weekly Expiry: Sensex mirrors Nifty's swings, but with milder spurts

The recent weekly expiry of Sensex showcased unexpected surges in the index and heightened options premiums. Traders observe that such fluct...